MXPA00003363A - Gel de dexametasona. - Google Patents

Gel de dexametasona.

Info

Publication number
MXPA00003363A
MXPA00003363A MXPA00003363A MXPA00003363A MXPA00003363A MX PA00003363 A MXPA00003363 A MX PA00003363A MX PA00003363 A MXPA00003363 A MX PA00003363A MX PA00003363 A MXPA00003363 A MX PA00003363A MX PA00003363 A MXPA00003363 A MX PA00003363A
Authority
MX
Mexico
Prior art keywords
dexamethasone
gel
dexamethasone gel
preparation
substance
Prior art date
Application number
MXPA00003363A
Other languages
English (en)
Inventor
Gunther Bellmann
Gudrun Claus-Herz
Christoph Kessler
Original Assignee
Gerhard Mann Chemisch Pharmaze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Mann Chemisch Pharmaze filed Critical Gerhard Mann Chemisch Pharmaze
Publication of MXPA00003363A publication Critical patent/MXPA00003363A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describe una preparacion oftalmologica que contiene dexametasona como sustancia activa, asi como aditivos comunes y agua, caracterizada porque contiene una cantidad de al menos una sustancia farmacologicamente aceptable, gelificante, suficiente para ajustar la viscosidad de la preparacion a una consistencia de gel.
MXPA00003363A 1997-10-06 1998-10-05 Gel de dexametasona. MXPA00003363A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19744113A DE19744113A1 (de) 1997-10-06 1997-10-06 Dexamethason-Gel
PCT/EP1998/006339 WO1999017780A1 (de) 1997-10-06 1998-10-05 Dexamethason-gel

Publications (1)

Publication Number Publication Date
MXPA00003363A true MXPA00003363A (es) 2007-12-07

Family

ID=7844743

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00003363A MXPA00003363A (es) 1997-10-06 1998-10-05 Gel de dexametasona.

Country Status (18)

Country Link
EP (1) EP1021192B1 (es)
JP (1) JP4156793B2 (es)
KR (1) KR100392481B1 (es)
CN (1) CN1142782C (es)
AR (1) AR017170A1 (es)
AT (1) ATE230601T1 (es)
BR (1) BR9812849A (es)
CA (1) CA2300806C (es)
DE (2) DE19744113A1 (es)
DK (1) DK1021192T3 (es)
ES (1) ES2191352T3 (es)
HK (1) HK1030748A1 (es)
HU (1) HU224986B1 (es)
IL (1) IL135001A0 (es)
MX (1) MXPA00003363A (es)
PL (1) PL189727B1 (es)
WO (1) WO1999017780A1 (es)
ZA (1) ZA989066B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
CN101190177B (zh) * 2006-11-24 2010-09-01 上海医药工业研究院 醋酸地塞米松局部成膜凝胶组合物及其应用
US20150190407A1 (en) * 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212392C3 (de) * 1972-03-15 1981-03-19 Avicon Inc., Fort Worth, Tex. Verwendung von mikrokristallinem Collagen zur Herstellung eines wäßrigen pharmazeutischen Mittels für die topische Anwendung am Auge
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4404990C1 (de) * 1994-02-17 1995-05-04 Mann Gerhard Chem Pharm Fab Verfahren zur Herstellung eines sterilen Prednisolongels
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
DK1021192T3 (da) 2003-05-05
CN1142782C (zh) 2004-03-24
WO1999017780A1 (de) 1999-04-15
WO1999017780A8 (de) 2000-01-27
DE59806884D1 (en) 2003-02-13
ES2191352T3 (es) 2003-09-01
CN1266369A (zh) 2000-09-13
HU224986B1 (en) 2006-05-29
CA2300806A1 (en) 1999-04-15
EP1021192A1 (de) 2000-07-26
ATE230601T1 (de) 2003-01-15
ZA989066B (en) 1999-06-15
KR100392481B1 (ko) 2003-07-23
JP4156793B2 (ja) 2008-09-24
HUP0003796A3 (en) 2001-05-28
HUP0003796A2 (hu) 2001-04-28
BR9812849A (pt) 2000-08-08
AR017170A1 (es) 2001-08-22
EP1021192B1 (de) 2003-01-08
CA2300806C (en) 2004-02-03
KR20010030939A (ko) 2001-04-16
JP2001518510A (ja) 2001-10-16
PL341026A1 (en) 2001-03-26
HK1030748A1 (en) 2001-05-18
DE19744113A1 (de) 1999-04-15
PL189727B1 (pl) 2005-09-30
IL135001A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
LU88694I2 (fr) Timolol ou un sel pharmaceutuquement acceptable de celui-ci en particulier le maléate de timolol en combinaison avec une gomme gélifiante
AU3951399A (en) Stable gel mixture in the form of a mixture of oleogel and aqueous gel
NO992980D0 (no) Nitroimidazol gelblanding
HK1036969A1 (en) Compounds and compositions for delivering active agents
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
UA37263C2 (uk) Протруйник та спосіб протруювання насіння
EP1027011A4 (en) ADMINISTRATION OF 5-HT RECEPTOR AGONISTS AND ANTAGONISTS INCLUDING ACTIVE SUBSTANCES FOR THE TREATMENT OF EARLY SEED EATING
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
PT836506E (pt) Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio
MX9803563A (es) Preparacion terapeutica para la administracion transdermica de principios activos.
GB2354167A (en) Gel cosmetic compositions
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
PL316177A1 (en) Transdermal system in the form of sticking plaster with a derivative of tamoxiphene as active substance
GR3019171T3 (en) System for delivering drug with enhanced bioacceptability.
CA2222698A1 (fr) Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
HK1042437A1 (en) Ophthalmic compositions in form of aqueous gels
MXPA00003363A (es) Gel de dexametasona.
GR3003539T3 (es)
DE69923832D1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
EP1676832A3 (en) Compounds and compositions for delivering active agents

Legal Events

Date Code Title Description
FG Grant or registration